Nearly 40 million people were living with HIV in 2017, the UN says, with just over half taking antiretroviral therapy. These drugs have cut AIDS-related deaths by more than half since the 2004 peak, but the disease cannot be cured. A new mechanism uncovered by a Norwegian research group could improve the chances of developing one.
An analysis of 5 000 proteins from a blood sample is providing valuable information on a variety of diseases we might get or be at risk for. “Sensational” is the word from Christian Jonasson at the HUNT Research Centre about the US-British-Norwegian study.
Cholesterol crystals form from “bad” cholesterol and are found in plaques that line blood vessels. When these plaques rupture, they can cause heart attacks or strokes. New research suggests that cholesterol crystals in plaques can actually trigger strokes and heart attacks.
Patients with chronic facial pain get their teeth pulled, take a bunch of painkillers and are on a perpetual trek between health services – without finding anything that works to ease the pain. An NTNU researcher thinks Botox can help.
A recently developed app with an in-built “enzyme calculator” reduces stomach pains and intestinal problems among patients with cystic fibrosis – a disease of the lungs and intestinal tract.
Metformin significantly reduces the risk of late miscarriages and preterm births for women with PCOS. But the drug does not work to prevent gestational diabetes, according to a large Nordic study from NTNU and St. Olavs hospital.
Sierra Leone has few doctors and even fewer surgeons to serve its seven million people. Since 2011, a non-profit group called CapaCare has been training community health officers to perform basic lifesaving surgeries. A new study shows the programme is working well when it comes to the most common surgery in the country — Caesarean sections.
Are you bothered by persistent pain? Here’s a pain physician’s advice on how to change your perceptions of pain and get a grip on it.
An enzyme that normally repairs damaged DNA may be the key to a new treatment for inflammatory diseases.
It took ten years of hard work. Authorities in many European countries have now approved a nasal spray developed in Norway that can reverse an opioid overdose.
Broad-spectrum antiviral drugs work against a range of viral diseases, but developing them can be costly and time consuming. Testing existing anti-viral drugs for their ability to combat multiple viral infections can help.
A treatment that kills the cancer cells in one fell swoop, without causing the patient to feel sick from the medication’s side effects? That’s the goal of new personalized cancer therapies that are being developed across the globe, including at NTNU.
A Norwegian-Swiss research team has succeeded in growing cartilage tissue cells using algae. Moreover, the new cells can reduce joint inflammation. This news gives hope for people suffering from arthrosis, also known as osteoarthritis.
New study results may help shorten queues to see the physiotherapist by reducing excessive treatment.
Many patients are treated for prostate cancer unnecessarily. Norwegian researchers are working to reduce overtreatment, while at the same time detecting the sickest patients. Now they’re receiving EU support.
A new approach to cancer treatment combines ultrasound, bubbles and nanoparticles with chemotherapy. In an experiment, the treatment has cured cancer in mice.
Omega-3 supplements may help slow the development of diseases like cancer, Alzheimer’s and multiple sclerosis.
Many cancer patients are susceptible to potentially lethal weight loss. Now researchers understand better why this happens, and perhaps how to prevent the condition.
A number of different medications are used to treat psychiatric disorders in Norwegian nursing homes. Even when residents’ symptoms show improvement over time, new research shows that many of them continue to be given the drugs.
People 65 and older benefit just as much from an operation for a slipped disc in the lower back as do younger patients.
What is the best form of first aid for a cold, injured body? Mountain medicine researchers are now co-operating to find the answer. At present there is actually no “best practice” for treating this type of patients.
Allergies to antibiotics are the commonest form of medication allergies and, in the worst cases, can result in anaphylaxis and death. SINTEF is participating in the development of a new allergy test that will make it easier to provide patients with safe and correct treatments.
Surgeons often take a blood vessel from your leg to graft onto your heart during a coronary bypass surgery. The practice can lead to scarring in many patients, which in turn can cause another heart attack. A new technique under development may help prevent this problem.
An enzyme found in many bacteria, including the bacterium that gives us strep throat, has given mankind a cheap and effective tool with which to edit our own genes. This technology, called CRISPR, is also being used to understand how the immune system responds to a viral attack.